Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant chemotherapy vs hepatectomy alone in low-risk recurrent colorectal cancer liver metastasis
ChiCTR2000037406Phase 3Not yet recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxaliplatin, fluorouracil and capecitabine in colorectal cancer (CRC) (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoint: Overall survival. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
oxaliplatinfluorouracilcapecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000037406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037406.